[Table/Fig-4]:

Significance values obtained after statistically analysing the serum AAT levels of the VKC patients, before and after treatment (by applying paired t-test)

Group/Sub-group	AAT level (mg/ml) of		p-value (paired t-test)
	VKC patients (acute stage)	VKC patients (after treatment)
Whole group	2.80 ± 0.42	2.48 ± 0.26	< 0.03
Males	2.82 ± 0.42	2.51 ± 0.28	< 0.03
Females	2.77 ± 0.40	2.44 ± 0.23	< 0.03
≤15 years	2.83 ± 0.42	2.52 ± 0.29	< 0.03
16-20 years	2.85 ± 0.45	2.46 ± 0.25	< 0.02
21-25 years	2.80 ± 0.35	2.43 ± 0.21	< 0.02
>25 years	2.74 ± 0.29	2.49 ± 0.17	< 0.03
Mild/Moderate	2.76 ± 0.41	2.43 ± 0.24	< 0.03
Severe	3.09 ± 0.25	2.88 ± 0.21	> 0.07